Cognitive decline following major surgery is associated with gliosis, &bgr;-amyloid accumulation, and &tgr; phosphorylation in old mice
暂无分享,去创建一个
M. Maze | M. Vizcaychipi | D. Ma | S. Gentleman | F. Meng | Jing Xu | N. Lobo | Yuhua Bao | Y. Ge | Y. Wan | Denghai Zhang
[1] D. Jeoung,et al. Celastrol suppresses allergen-induced airway inflammation in a mouse allergic asthma model. , 2009, European journal of pharmacology.
[2] L. Rasmussen,et al. Long-term Consequences of Postoperative Cognitive Dysfunction , 2009, Anesthesiology.
[3] R. W. Johnson,et al. Neuroinflammation and cognitive function in aged mice following minor surgery , 2008, Experimental Gerontology.
[4] Yong-Ki Park,et al. Celastrol inhibits production of nitric oxide and proinflammatory cytokines through MAPK signal transduction and NF-κB in LPS-stimulated BV-2 microglial cells , 2007, Experimental & Molecular Medicine.
[5] D. Butterfield,et al. Roles of amyloid β-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment , 2007 .
[6] B. Aggarwal,et al. Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation. , 2007, Blood.
[7] M. Maze,et al. Postoperative Impairment of Cognitive Function in Rats: A Possible Role for Cytokine-mediated Inflammation in the Hippocampus , 2007, Anesthesiology.
[8] R. Tanzi,et al. The Inhalation Anesthetic Isoflurane Induces a Vicious Cycle of Apoptosis and Amyloid β-Protein Accumulation , 2007, The Journal of Neuroscience.
[9] Colin L Masters,et al. Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics , 2006, Journal of neurochemistry.
[10] M. Beal,et al. Celastrol Blocks Neuronal Cell Death and Extends Life in Transgenic Mouse Model of Amyotrophic Lateral Sclerosis , 2006, Neurodegenerative Diseases.
[11] R. Tanzi. Tangles and neurodegenerative disease--a surprising twist. , 2005, The New England journal of medicine.
[12] C. Eckman,et al. Aβ-degrading enzymes: modulators of Alzheimer's disease pathogenesis and targets for therapeutic intervention , 2005 .
[13] M. Higuchi,et al. Understanding molecular mechanisms of proteolysis in Alzheimer's disease: progress toward therapeutic interventions. , 2005, Biochimica et biophysica acta.
[14] M. Beal,et al. Celastrol protects against MPTP‐ and 3‐nitropropionic acid‐induced neurotoxicity , 2005, Journal of neurochemistry.
[15] M. MacDonald,et al. Reversal of a full-length mutant huntingtin neuronal cell phenotype by chemical inhibitors of polyglutamine-mediated aggregation , 2005, BMC Neuroscience.
[16] M. Eckenhoff,et al. Inhaled Anesthetic Enhancement of Amyloid-&bgr; Oligomerization and Cytotoxicity , 2004, Anesthesiology.
[17] M. Otto,et al. Role of interleukin-1 in prion disease-associated astrocyte activation. , 2004, The American journal of pathology.
[18] R. Tanzi,et al. Hypocapnia Induces Caspase-3 Activation and Increases Aβ Production , 2004, Neurodegenerative Diseases.
[19] Z. Qiu,et al. [The experimental study on the inhibitory effect of tripterine on airway inflammation in asthmatic mice]. , 2004, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases.
[20] A. Bekker,et al. Cognitive function after anaesthesia in the elderly. , 2003, Best practice & research. Clinical anaesthesiology.
[21] Qian Sun,et al. Beta-amyloid secretases and beta-amloid degrading enzyme expression in lens. , 2003, Molecular vision.
[22] M. Puder,et al. Partial Hepatectomy in the Mouse: Technique and Perioperative Management , 2003, Journal of investigative surgery : the official journal of the Academy of Surgical Research.
[23] P. Kochanek,et al. Changes in expression of amyloid precursor protein and interleukin-1beta after experimental traumatic brain injury in rats. , 2002, Journal of neurotrauma.
[24] P. Lipsky,et al. Benefit of an extract of Tripterygium Wilfordii Hook F in patients with rheumatoid arthritis: a double-blind, placebo-controlled study. , 2002, Arthritis and rheumatism.
[25] C. Peers,et al. Hypoxia potentiates exocytosis and Ca2+ channels in PC12 cells via increased amyloid β peptide formation and reactive oxygen species generation , 2002, The Journal of physiology.
[26] G. Lenzi,et al. A case-control study on Alzheimer’s disease and exposure to anesthesia , 2002, Neurological Sciences.
[27] W. White,et al. Report of the Substudy Assessing the Impact of Neurocognitive Function on Quality of Life 5 Years After Cardiac Surgery , 2001, Stroke.
[28] A. Allison,et al. Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease , 2001, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[29] D. Dickson,et al. Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP , 2001, Science.
[30] Erry,et al. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. , 2001, The New England journal of medicine.
[31] C. Plata-salamán,et al. Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.
[32] C. Bergeron,et al. Caspase-6 Role in Apoptosis of Human Neurons, Amyloidogenesis, and Alzheimer’s Disease* , 1999, The Journal of Biological Chemistry.
[33] M. A. Colivicchi,et al. Interleukin-1β activates forebrain glial cells and increases nitric oxide production and cortical glutamate and GABA release in vivo: implications for Alzheimer's disease , 1999, Neuroscience.
[34] M. Mattson,et al. Amyloid β-peptide induces apoptosis-related events in synapses and dendrites , 1998, Brain Research.
[35] P. Rabbitt,et al. Long-term postoperative cognitive dysfunction in the elderly: ISPOCD1 study , 1998, The Lancet.
[36] W. Griffin,et al. Glial‐Neuronal Interactions in Alzheimer's Disease: The Potential Role of a ‘Cytokine Cycle’ in Disease Progression , 1998, Brain pathology.
[37] H. Li,et al. Effect of tripterine on collagen-induced arthritis in rats. , 1997, Zhongguo yao li xue bao = Acta pharmacologica Sinica.
[38] S. Younkin,et al. The Alternatively Spliced Kunitz Protease Inhibitor Domain Alters Amyloid β Protein Precursor Processing and Amyloid β Protein Production in Cultured Cells* , 1996, The Journal of Biological Chemistry.
[39] P. Mcgeer,et al. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases , 1995, Brain Research Reviews.
[40] D. Munoz,et al. Role of microglia in senile plaque formation , 1995, Neurobiology of Aging.
[41] C. Cotman,et al. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[42] G. Forloni,et al. Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25-35. , 1993, Neuroreport.
[43] C. Finch,et al. Relation of neuronal APP-751/APP-695 mRNA ratio and neuritic plaque density in Alzheimer's disease. , 1990, Science.
[44] M. Shin,et al. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[45] L. Villa-komaroff,et al. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. , 1989, Science.
[46] Andreas Weidemann,et al. Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein , 1989, Cell.
[47] L. Lachman,et al. Interleukin 1 of the central nervous system is produced by ameboid microglia , 1986, The Journal of experimental medicine.
[48] D. Butterfield,et al. Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment. , 2007, Free radical biology & medicine.
[49] A. Chow,et al. Induction of heat shock proteins in differentiated human and rodent neurons by celastrol , 2007, Cell stress & chaperones.
[50] Alexandra Flemming,et al. Infectious disease: Unravelling SARS lethality , 2005, Nature Reviews Drug Discovery.
[51] M. A. Colivicchi,et al. Interleukin-1beta activates forebrain glial cells and increases nitric oxide production and cortical glutamate and GABA release in vivo: implications for Alzheimer's disease. , 1999, Neuroscience.
[52] M. Mattson,et al. Amyloid beta-peptide induces apoptosis-related events in synapses and dendrites. , 1998, Brain research.
[53] S. Younkin,et al. The alternatively spliced Kunitz protease inhibitor domain alters amyloid beta protein precursor processing and amyloid beta protein production in cultured cells. , 1996, The Journal of biological chemistry.
[54] N. Bohnen,et al. Early and midlife exposure to anesthesia and age of onset of Alzheimer's disease. , 1994, The International journal of neuroscience.
[55] J. Guo,et al. Tripterygium wilfordii Hook f in rheumatoid arthritis and ankylosing spondylitis. Preliminary report. , 1981, Chinese medical journal.